| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.005 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.098 | 0.006 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.008 |